Hall Estill Law Firm
2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress
Novel 2,4-diaminoquinazoline derivatives are disclosed. The compounds can be used in treating diseases and conditions which are associated with abnormal cell function related to endoplasmic reticulum (ER) stress. For example, the compounds can be used as suppressors of ER stress-induced pancreatic β-cell dysfunction and death, for example in the treatment of diabetes.
The Board of Regents of the University of Oklahoma
C C A A
C07D C07D A61K A61P
inventional inventional inventional inventional
Jae Wook Weidong
Lee Wang